Literature DB >> 18191395

Human papillomavirus infection in women with and without cervical cancer in Warsaw, Poland.

A Bardin1, S Vaccarella, G M Clifford, J Lissowska, M Rekosz, P Bobkiewicz, J Kupryjańczyk, R Krynicki, J Jonska-Gmyrek, A Danska-Bidzinska, P J F Snijders, C J L M Meijer, W Zatonski, S Franceschi.   

Abstract

Cervical cancer incidence and mortality in Poland is among the highest in Europe. To investigate infection with different human papillomaviruses (HPV) in Warsaw, Poland, we obtained cervical cell specimens from 834 women aged 18-59 years from the general population, and 88 cervical cancers. DNA of 44 HPV types was detected using a GP5+/6+-based PCR assay. HPV prevalence was 16.6% in the general female population, being highest (24.2%) in women aged 25-34 years, notably among unmarried women (37.3%). HPV prevalence fell to 8.6% at ages 55-59. High-risk HPV prevalence was 11.3%, with HPV16 being the most common type (3.7%). All but one cervical cancer were high-risk HPV-positive, although the importance of HPV16 (73%) was much greater, and multiple infections fewer (1%), than among HPV-positive women in the general female population. In summary, we report a relatively high burden of HPV infection in Warsaw, Poland, where 79% of cervical cancers are theoretically preventable by HPV16/18 vaccines.

Entities:  

Mesh:

Year:  2008        PMID: 18191395     DOI: 10.1016/j.ejca.2007.12.001

Source DB:  PubMed          Journal:  Eur J Cancer        ISSN: 0959-8049            Impact factor:   9.162


  21 in total

1.  Trends in cervical cancer incidence and mortality in Poland: is there an impact of the introduction of the organised screening?

Authors:  Andrzej Nowakowski; Urszula Wojciechowska; Paulina Wieszczy; Marek Cybulski; Michał F Kamiński; Joanna Didkowska
Journal:  Eur J Epidemiol       Date:  2017-08-05       Impact factor: 8.082

2.  Human papillomavirus 45 genetic variation and cervical cancer risk worldwide.

Authors:  Alyce A Chen; Daniëlle A M Heideman; Debby Boon; Tarik Gheit; Peter J F Snijders; Massimo Tommasino; Silvia Franceschi; Gary M Clifford
Journal:  J Virol       Date:  2014-02-05       Impact factor: 5.103

3.  Comparison of HPV Testing and Colposcopy in Detecting Cervical Dysplasia in Patients With Cytological Abnormalities.

Authors:  Joanna Świderska-Kiec; Krzysztof Czajkowski; Julia Zaręba-Szczudlik; Joanna Kacperczyk-Bartnik; Paweł Bartnik; Ewa Romejko-Wolniewicz
Journal:  In Vivo       Date:  2020 May-Jun       Impact factor: 2.155

4.  Human Papillomavirus 18 Genetic Variation and Cervical Cancer Risk Worldwide.

Authors:  Alyce A Chen; Tarik Gheit; Silvia Franceschi; Massimo Tommasino; Gary M Clifford
Journal:  J Virol       Date:  2015-08-12       Impact factor: 5.103

5.  Human papillomavirus 33 worldwide genetic variation and associated risk of cervical cancer.

Authors:  Alyce A Chen; Daniëlle A M Heideman; Debby Boon; Zigui Chen; Robert D Burk; Hugo De Vuyst; Tarik Gheit; Peter J F Snijders; Massimo Tommasino; Silvia Franceschi; Gary M Clifford
Journal:  Virology       Date:  2013-11-12       Impact factor: 3.616

6.  HPV genotypes in the oral cavity/oropharynx of children and adolescents: cross-sectional survey in Poland.

Authors:  Julia Durzyńska; Joanna Pacholska-Bogalska; Maria Kaczmarek; Tomasz Hanć; Magdalena Durda; Magdalena Skrzypczak; Anna Goździcka-Józefiak
Journal:  Eur J Pediatr       Date:  2010-11-24       Impact factor: 3.183

7.  Human papillomavirus genotype distribution in Czech women and men with diseases etiologically linked to HPV.

Authors:  Ruth Tachezy; Jana Smahelova; Martina Salakova; Marc Arbyn; Lukas Rob; Petr Skapa; Tomas Jirasek; Eva Hamsikova
Journal:  PLoS One       Date:  2011-07-13       Impact factor: 3.240

8.  HPV-type distribution and reproducibility of histological diagnosis in cervical neoplasia in Poland.

Authors:  Andrzej Nowakowski; Sabrina Collas de Souza; Robert Jach; Dominique Rosillon; Alicja Książek; Katsiaryna Holl
Journal:  Pathol Oncol Res       Date:  2014-12-30       Impact factor: 3.201

9.  Differences in the risk of cervical cancer and human papillomavirus infection by education level.

Authors:  S Franceschi; M Plummer; G Clifford; S de Sanjose; X Bosch; R Herrero; N Muñoz; S Vaccarella
Journal:  Br J Cancer       Date:  2009-08-04       Impact factor: 7.640

10.  Difference in overall and age-specific prevalence of high-risk human papillomavirus infection in Italy: evidence from NTCC trial.

Authors:  Iacopo Baussano; Silvia Franceschi; Anna Gillio-Tos; Francesca Carozzi; Massimo Confortini; Paolo Dalla Palma; Margherita De Lillo; Annarosa Del Mistro; Laura De Marco; Carlo Naldoni; Paola Pierotti; Patrizia Schincaglia; Nereo Segnan; Manuel Zorzi; Paolo Giorgi-Rossi; Guglielmo Ronco
Journal:  BMC Infect Dis       Date:  2013-05-24       Impact factor: 3.090

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.